Clinical trial
Combination Chemotherapy With or Without G-CSF in Treating Patients With…
NCT00416910 · German CLL Study Group, Other · Terminated
Key facts
| NCT number | NCT00416910 |
|---|---|
| Title | Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia |
| Official title | Treatment of Advanced Chronic Lymphocytic Leukemia (CLL) Fludarabine, Mitoxantrone and Cyclophosphamide With or Without G-CSF |
| Lead sponsor | German CLL Study Group, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Biological, Drug |
| Interventions | Filgrastim, Fludarabine, Cyclophosphamide, Mitoxantrone |
| Enrollment | 83 |
| Start date | Jul 1, 1999 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2007 |
| First posted | Dec 28, 2006 |
| Last update posted | Sep 26, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: